FDA Approves New Drug For Cushing’s

The F-D-A has approved a new drug to treat Cushing’s disease. Isturisa (osilodrostat) oral tablets from Novartis are aimed at adults who are not candidates for surgery or who have experienced a recurrence post-surgery.fda It is the first FDA-approved drug that blocks 11-beta-hydroxylase and prevents cortisol synthesis in order to control cortisol overproduction. Read the FDA press release: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-cushings-diseasehttps://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-cushings-disease


Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now